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Rac is required for constitutive macropinocytosis by dendritic
cells but does not control its downregulation
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Background: Dendritic cells use constitutive macropinocytosis to capture
exogenous antigens for presentation on MHC molecules. Upon exposure to
inflammatory stimuli or bacterial products such as lipopolysaccharide (LPS),
macropinocytosis is dramatically downregulated as part of a developmental
programme leading to dendritic cell maturation, migration and activation of
T cells. It is not known, however, how macropinocytosis is sustained in dendritic
cells in the absence of exogenous stimuli, nor how it is downregulated upon
maturation. We have tested the possibility that one or more members of the
Rho family of GTPases are involved in and control pinocytosis in dendritic cells. 
Results: We established dendritic cell populations that show constitutive
macropinocytosis that was downregulated by LPS treatment. Microinjection of
immature cells with dominant-negative Rac (N17Rac1) or treatment with
Clostridium difficile toxin B, the phosphoinositide 3-kinase (PI3-K) inhibitor
wortmannin, or LPS all inhibited the formation of macropinosomes but,
surprisingly, did not eliminate membrane ruffling. Microinjection of N17Cdc42
or the Rho inhibitor C3 transferase eliminated actin plaques/podosomes and
actin cables, respectively, but had little effect on the formation of
macropinosomes. Surprisingly, dendritic cells matured with LPS had equivalent
or even somewhat higher levels of active Rac than immature cells. Moreover,
microinjection of a constitutively active form of Rac (V12Rac1) into mature
dendritic cells did not reactivate macropinocytosis.
Conclusions: Rac has an important role in the constitutive formation of
macropinosomes in dendritic cells but may be required downstream of
membrane ruffling. Furthermore, regulation of Rac activity does not appear to
be the control point in the physiological downregulation of dendritic cell
pinocytosis. Instead, one or more downstream effectors may be modulated to
allow Rac to continue to regulate other cellular functions.
Background
Dendritic cells have a crucial role in the immune
response, being unique in their ability to effectively
trigger a primary T-cell response to foreign antigen [1].
Dendritic cells exist in distinct developmental states,
which allows them to fulfil their roles in antigen capture
and presentation. Immature bone-marrow-derived den-
dritic cells seed the peripheral tissues, sampling and pro-
cessing the antigens they encounter. In response to local
inflammatory stimuli or infectious agents, dendritic cells
undergo a maturation process during which they migrate
to secondary lymphoid organs where they present previ-
ously captured antigenic material to naive T cells. In vitro
recapitulation of these events has revealed that dendritic
cells upregulate the expression of MHC molecules, adhe-
sion molecules and co-stimulatory molecules and down-
regulate their endocytotic capacity as part of this
developmental programme [1–4].
Macropinocytosis has emerged as a key antigen uptake
pathway by which dendritic cells can rapidly and non-
specifically sample large amounts of surrounding fluid [5–7].
Exogenous antigen taken up by this route can be processed
and presented to T cells on both MHC class I and class II
molecules [6,7]. Macropinosomes are large (~0.2–5.0 mm
diameter) endocytic structures which form when membrane
ruffles fuse together, non-selectively engulfing fluid-phase
material [8]. Particularly striking in dendritic cells is the fact
that membrane ruffling and macropinocytosis are constitu-
tive [6,7], whereas in fibroblasts, epithelial cells and most
other cell types studied, these events require stimulation by
growth factors [9–12]. Moreover, in cultured human mono-
cyte-derived dendritic cells at least, macropinocytosis is
downregulated by inflammatory stimuli [6].
The Rho-family GTPases Rac, Rho and Cdc42 are major
regulators of the actin cytoskeleton. In fibroblasts, Rac
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activation leads to membrane ruffling and pinocytosis [13].
Parallel roles for Rho in regulating the assembly of focal
adhesions and stress fibres and for Cdc42 in the formation
of peripheral filopodia have also been identified [14–16].
Subsequently, many other studies have confirmed a role
for Rac in stimulating ruffling and lamellipodium exten-
sion in a variety of different cell types, including lympho-
cytes, macrophages, mast cells and neurons. Rac has also
been implicated in the regulation of related cellular
processes such as adhesion, cell spreading, migration,
axonal extension and phagocytosis [15,17–23]. Rac is also
known to be a regulatory component of NADPH oxidase
in phagocytes and a component of signal transduction
pathways linking growth factors to the regulation of gene
expression and cell proliferation [24–26].
We have investigated two key issues relating to the regu-
lation of macropinocytosis in dendritic cells: first, how
immature dendritic cells maintain such high levels of
constitutive macropinocytosis, and second, how this
activity is downregulated in response to inflammatory
stimuli. Specifically, we have investigated the role of
Rho-family GTPases in these events. We find a clear
requirement for Rac for constitutive macropinocytosis in
dendritic cells, but, interestingly, ruffling and formation
of macropinosomes appear to be separately regulated.
Developmental downregulation of macropinocytosis in
this system is not accompanied by a measurable decrease
in levels of active Rac, suggesting that one or more
downstream elements of the pathway are developmen-
tally regulated.
Results
Spleen-derived murine dendritic cells exhibit high levels of
macropinocytosis which can be downregulated by LPS
To investigate the regulation of macropinocytosis in den-
dritic cells, we have adopted a system for culturing
primary spleen-derived dendritic cells (SDCs) in the short
to medium term [27]. Murine splenocytes are isolated and
cultured in the presence of granulocyte–macrophage
colony-stimulating factor (GM–CSF), a cytokine essential
for dendritic cell growth, and transforming growth factor-b
(TGF-b), which has been shown to support the outgrowth
of immature, Langerhans-type dendritic cells [28–30].
After approximately 14 days, the cultures are highly
enriched for dendritic cells compared with the starting
population, as judged by FACS analysis of expression of
markers for B cells, T cells and dendritic cells. The den-
dritic cell integrin CD11c was almost undetectable in the
starting population, but was expressed on the majority of
cells cultured in GM–CSF and TGF-b. B and T cells,
which were abundant in the starting population, were
absent from the final SDC population (see Supplementary
material). A large proportion of cells in the starting popula-
tion (presumably B cells) also expressed high levels of
MHC class II molecules, which were much reduced on
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Selective downregulation of constitutive macropinocytosis in
LPS-treated spleen dendritic cells (SDCs). (a) Immature SDCs after
14 days culture (first panels), SDCs that had been starved of growth
factors and serum for 3 h (second panels), and the B and T cell lines
A20 and EL4 (third and fourth panels, respectively) were incubated
with 1.5 mg/ml FITC–dextran for 20 min at 37°C. In the fluorescence
micrographs (top panels), macropinosomes are visible as large
fluorescently labelled vacuoles in SDCs, but not in B or T cells.
Corresponding differential interference contrast (DIC) images are
shown in the bottom panels. (b) LPS-treated (+LPS) and
untreated (–LPS) SDCs (mSDCs and iSDCs, respectively) were
analysed for macropinocytosis as in (a). No FITC–dextran-labelled
macropinosomes were detectable in mSDCs after 10 min. The scale
bars represent 10 mm.
immature SDCs. SDCs also expressed DEC-205 and
other markers associated with immature dendritic cells. 
To compare the endocytic capacity of SDCs with that of
other cell types, we followed the uptake of the fluid-
phase marker FITC–dextran. Within minutes, SDCs
formed many large (> 300 nm diameter) FITC-labelled
macropinosomes (Figure 1a). Remarkably, removal of
GM–CSF, TGF-b and serum for 3 hours did not abolish
macropinocytosis (Figure 1a), confirming that this process
is constitutive in immature murine SDCs, as it is in
human monocyte-derived dendritic cells [6]. In contrast,
B and T lymphocytes showed no evidence of FITC
uptake into macropinocytic structures over this time
scale, although smaller labelled structures, probably rep-
resenting conventional endocytic vesicles, were just
detectable (Figure 1a).
Immature dendritic cells can be induced to differentiate
into mature dendritic cells by treatment in vitro with a
variety of inflammatory stimuli or infectious agents, includ-
ing bacterial products such as LPS [31–34]. To test whether
we could drive the maturation of SDCs, we pre-treated the
cells for 40 hours with LPS and then assessed their capacity
for macropinocytosis. Uptake of FITC–dextran into
macropinosomes was dramatically reduced compared with
untreated cells demonstrating that our culture system gen-
erates dendritic cells that display an authentic LPS-regu-
lated pinocytic response (Figure 1b). We refer to the
LPS-treated and untreated cells as mature SDCs (mSDCs)
and immature SDCs (iSDCs), respectively. In parallel, we
also quantitated the number of clathrin-coated pits and
vesicles as markers of the conventional micropinocytic
pathway. Whereas iSDCs had 6.0 ± 1.15 coated pits per
100 mm cell surface, on mSDCs this was reduced, but only
to a small extent (5.0 ± 0.79 pits per 100 mm cell surface).
Thus there is a selective downregulation of macropinocyto-
sis on SDC maturation. 
Dominant-negative Rac specifically inhibits
macropinocytosis in immature SDCs
To test the possible role of Rho-family GTPases in the
maintenance of constitutive macropinocytosis in SDCs,
we first exposed the iSDCs to Clostridium difficile toxin B,
which has been shown specifically to glucosylate Rac, Rho
and Cdc42 and inhibit their function [35]. Macropinocyto-
sis in iSDCs was strongly inhibited under these conditions
(only 14% of treated cells had labelled pinosomes com-
pared with 92% of untreated cells), indicating that one or
more members of this GTPase family are required to
maintain constitutive macropinocytosis. To test the
requirement for Rac, Cdc42 and Rho individually we
microinjected N17Rac1, N17Cdc42 or C. botulinum C3
transferase to block endogenous Rac, Cdc42 and Rho
function, respectively [13]. We also established a rigorous
new test to ensure that only viable cells were analysed
after microinjection. The naturally fluorescent protein
allophycocyanin (APC) was conjugated to a nuclear
localisation signal peptide (NLS) and co-injected into
the cytosol. APC–NLS translocates into and accumulates
in the nucleus in an energy-dependent manner, provid-
ing not just a marker for identifying injected cells, but
also an indicator of cell viability following microinjec-
tion. Only cells with clearly fluorescent nuclei were con-
sidered in these experiments. After microinjection, the
cells were incubated at 37°C for 20 minutes and then
exposed to FITC–dextran for 10 minutes to label newly
forming macropinosomes.
Cells injected with APC–NLS alone, or with APC–NLS
and the inactive mutant A35Rac1 [13] as controls, exhib-
ited large FITC-labelled pinosomes, also seen in neigh-
bouring non-injected cells (Figure 2a, top and middle
panels). Cells injected with N17Rac1, however, failed to
macropinocytose FITC–dextran (Figure 2a, bottom panel).
Microinjected cells were scored positive in this assay if
they formed one or more FITC-labelled macropinosomes
in 10 minutes. Quantitation from four independent exper-
iments, scoring a total of 450 N17Rac1-injected cells, con-
firmed that N17Rac1 completely inhibited macropinocytosis
in immature SDCs (Figure 2b). The Rac-related GTPases
Rho and Cdc42 also regulate actin cytoskeleton rearrange-
ments and Rac, Rho and Cdc42 have all been implicated
in phagocytosis, another actin-dependent endocytic
pathway [22,23,36]. We tested the specific Rho inhibitor
C3 transferase and a dominant-negative mutant of Cdc42,
N17Cdc42, for their effects on  macropinocytosis in
iSDCs. As shown in Figure 2c, both inhibitors caused a
small reduction in the percentage of injected cells
showing labelled macropinosomes. The effects were mod-
erate compared with the more dramatic inhibition of
macropinocytosis observed with N17Rac1 (Figure 2b),
and may be indirectly due to changes in cell morphology.
Both C3 transferase and N17Cdc42 induced clear-cut
effects on other actin-based cytoskeletal structures in
SDCs, however. Microinjection with N17Cdc42 reduced
or abolished clusters of distinct actin plaques observed in
SDCs whereas microinjection of recombinant C3 trans-
ferase specifically eliminated actin cables. Neither of these
inhibitors affected the presence of membrane ruffles. Quan-
titation of these effects of C3 transferase and N17Cdc42 is
shown in Figure 2d; representative images used for this
analysis can be seen in Supplementary material. 
Persistence of membrane ruffles in the absence of
macropinosome formation
Because active Rac is required for growth-factor-stimu-
lated membrane ruffling in a number of cell types and for
constitutive macropinocytosis in SDCs, it seemed likely
that N17Rac1 inhibited macropinocytosis in iSDCs
by inhibiting the formation of membrane ruffles, which
are the precursors of macropinosomes. To test this, we
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performed double-labelling experiments in which phal-
loidin-labelled actin structures and macropinosomes con-
taining FITC–dextran could be observed in the same
injected cells. Surprisingly, although N17Rac1-injected
iSDCs were essentially devoid of macropinosomes, they
still displayed actin-rich membrane ruffles (Figure 3a).
Control experiments clearly showed that the same prepa-
ration of N17Rac1, when injected into quiescent Swiss
3T3 fibroblasts, effectively blocked ruffling in response
to phorbol ester stimulation (data not shown). As an alter-
native means of inhibiting Rac function, we treated
iSDCs with toxin B for 30 minutes and then assessed
the same cells for the presence of ruffles and labelled
macropinosomes. Membrane ruffles were still strikingly
evident on cells treated with toxin B, although the mor-
phology of the ruffles was somewhat different
(Figure 3a). Nonetheless, macropinosome formation was
completely abolished (Figure 3a). Thus, constitutive ruf-
fling in iSDCs appears to be much less dependent on Rac
function than in other cell types, in which exogenous
stimuli are used to induce it. 
PI3-K has been implicated in growth-factor-stimulated
ruffling and fluid-phase pinocytosis [37–40]. When we
tested the effects of the PI3-K inhibitor wortmannin on
ruffling and macropinocytosis in SDCs, we made essen-
tially the same observation: macropinocytosis was virtu-
ally eliminated, whereas phalloidin-stained membrane
ruffles could still be seen in the same treated cells
(Figure 3a). Finally, membrane ruffles or veils were still
abundant, or indeed more pronounced, under conditions
where macropinocytosis was inhibited by LPS-driven
SDC maturation (Figure 3a). The effects of N17Rac1,
toxin B, wortmannin and LPS on the presence of mem-
brane ruffles and labelled macropinosomes were quanti-
tated in the same cells. The results clearly show that
while all four treatments inhibited macropinocytosis,
membrane ruffles persisted, indicating the existence of
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Figure 2
Rac is specifically required for constitutive
macropinocytosis in SDCs. (a) iSDCs were
microinjected with APC–NLS alone (top), or
with APC–NLS and A35Rac1 (middle) or
N17Rac1 (bottom), then exposed to
FITC–dextran for 10 min at 37°C. Cells that
had taken up APC–NLS into the nucleus
(shown in red) were scored for the presence
or absence of any FITC-labelled
macropinosomes (green). DIC images of the
same cells are shown on the right.
(b) Quantitation of the results shown in (a)
from four independent experiments scoring a
total of 450 N17Rac1-injected cells. The
percentage of non-injected cells showing
labelled macropinosomes after incubation at
either 4°C or 37°C is also shown. The effect
of microinjected N17Cdc42 and C3
transferase on (c) constitutive
macropinocytosis and (d) actin plaques,
cables and ruffles, was assessed following
microinjection. Data are expressed as the
mean of three independent experiments for
N17Cdc42 (540 injected cells scored) or
shows a representative experiment of two
performed for C3 transferase (180 cells
scored). Representative images of cells used
to collect the data in (d) can be viewed in
Supplementary material. The scale bar in (a)
represents 10 mm.
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additional points of regulation for macropinocytosis in
SDCs (Figure 3b).
Levels of active Rac, Cdc42 and Vav in iSDCs versus mSDCs 
Because active Rac is required for constitutive
macropinocytosis in iSDCs, a potential mechanism for the
downregulation of pinocytosis in mature cells would be
through a reduction in levels of Rac protein or Rac–GTP.
To test this hypothesis, we used a fusion protein compris-
ing a p21-activated kinase (PAK) CRIB domain fused to
glutathione-S-transferase (GST), which specifically binds
Rac–GTP and Cdc42–GTP but not the inactive GDP-
bound forms, to directly measure levels of active Rac in
lysates from LPS-treated and untreated SDCs [41–43]. As
shown in Figure 4a, when Rac present in SDC lysates was
loaded with GDP or the poorly hydrolysable GTP ana-
logue GTPgS, the GST–PAK fusion protein selectively
precipitated GTP-bound rather than GDP-bound Rac.
We then prepared lysates from iSDCs and mSDCs and
performed Rac affinity precipitations using the GST–PAK
fusion protein. Rac could clearly be precipitated from
iSDC lysates with GST–PAK, whereas in a control precip-
itation with GST alone, no Rac was detected by western
blotting (Figure 4a). When we carried out a precipitation
from mSDC, however, rather than showing a reduced
amount of active Rac, LPS-matured SDCs had two- to
threefold higher levels of PAK-precipitable Rac
(Figure 4a). Total Rac levels in the lysates from iSDCs
and mSDCs were essentially unchanged (Figure 4a, lower
panel). The overall consensus from seven experiments,
each of which showed efficient LPS-driven downregula-
tion of macropinocytosis, was that Rac activity either
increased or remained essentially the same. This striking
result indicates that whereas Rac activity is clearly
required for constitutive macropinocytosis, this does not
appear to be the control point for the developmental regu-
lation of macropinocytosis. A similar analysis was per-
formed for Cdc42, which also interacts with the PAK
CRIB domain [44]. As shown in Figure 4b, there was also
a detectable and reproducible small increase in the
amount of precipitable Cdc42 in LPS-matured cells.
We also assessed two other potential indicators of Rac
activity, membrane association of Rac and levels of the
guanine-nucleotide exchange factor (GEF) Vav. We frac-
tionated LPS-treated and untreated SDCs into mem-
brane/cytoskeleton and cytosolic pools, and quantitated
the levels of Rac in each by western blotting. A small
percentage of total Rac was recovered in the mem-
brane/cytoskeleton fraction in iSDCs, but could be
increased fivefold by incubating the lysates in the pres-
ence of GTPgS (Figure 4c). Levels of membrane-associ-
ated Rac in samples from LPS-treated SDCs were
virtually unchanged, however, (11% of total after subtrac-
tion of background due to cytosol contamination) com-
pared with untreated samples (12%), supporting the
previous observation that Rac–GTP levels were not
reduced in LPS-matured cells (Figure 4a). Vav is
expressed in haematopoietic cells [45] and is known to
stimulate nucleotide exchange on Rac [46]. Vav activity is
dependent on tyrosine phosphorylation by the Src-family
kinase Lck, and can be regulated both directly and indi-
rectly by products of PI3-K [47]. We compared levels of
total and tyrosine-phoshorylated Vav immunoprecipitated
Research Paper  Macropinocytosis in dendritic cells West et al. 843
Figure 3
Membrane ruffles persist in the absence of
macropinosome formation in SDCs. iSDCs
were microinjected with APC–NLS alone or
with APC–NLS together with N17Rac1, or
were treated with toxin B or wortmannin, or
induced to mature with LPS. (a) SDCs were
exposed to FITC–dextran for 10 min to label
macropinosomes (shown in red), then fixed
and stained for actin with TRITC–phalloidin
(shown in green). Microinjected cells have
blue/cyan nuclei. Persisting ruffles in injected
cells are indicated with arrows. (b) For each
condition, the percentage of cells that
displayed actin-rich ruffles was determined
(white bars), and among those cells, the
percentage also containing any labelled
macropinosomes was assessed (black
portions of the bars). The scale bars in (a)
represent 10 mm.
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from lysates of immature or LPS-treated SDCs, and found
that although total Vav was slightly reduced, the extent of
phosphorylation, and therefore the level of potentially
active Vav, was actually elevated in mature cells
(Figure 4d). Thus, neither the activity of Rac, nor its
membrane localisation, nor the level of the active form of
at least one GEF for Rac are downregulated upon den-
dritic cell maturation, in spite of the fact that Rac-depen-
dent macropinocytosis is completely shut down. 
Constitutively active Rac does not overcome the
downregulation of macropinocytosis in mature SDCs
To strengthen our conclusion that downregulation of
pinocytosis in mature SDCs is not controlled by downreg-
ulation of Rac activity, we microinjected a constitutively
active mutant of Rac (V12Rac1) into LPS-treated SDCs.
V12Rac1 stimulates ruffling and macropinocytosis in
fibroblasts [13]. After a short incubation period, we
exposed the injected cells to FITC–dextran to assay
macropinosome formation. As shown in Figure 5, there
was no significant increase in macropinosome formation in
V12Rac1-injected mature cells compared with neighbour-
ing uninjected cells, and levels of macropinocytosis
remained far below those in untreated iSDCs. The prepa-
ration of V12Rac1 was fully active, as judged by its ability
to induce membrane ruffles in 85% of quiescent Swiss
3T3 fibroblasts. V12Cdc42 was also unable to restimulate
macropinocytosis in mature SDCs (data not shown). Thus
downregulation of constitutive macropinocytosis does not
appear to be induced by decreased Rac activity in imma-
ture SDCs, nor could it be reactivated in mature SDCs by
manipulation of the levels of active Rac. 
Discussion 
Although the significance of macropinocytosis in many
cell types is not obvious, it has considerable physiological
relevance in dendritic cells, enabling the non-specific
sampling of proteins in the external milieu and display of
processed peptides on MHC molecules. Furthermore, this
feature of the immune-stimulatory arsenal of dendritic
cells is subject to unusual regulation, being constitutive in
immature cells and downregulated upon cell maturation.
This makes biological sense, distinguishing a phase of
antigen capture in peripheral tissues from a phase of
antigen presentation after dendritic cell migration to lym-
phoid tissue [1]. The persistence of MHC–peptide com-
plexes formed in immature cells is likely to be aided by
low rates of endocytosis and membrane turnover [6]. 
To study this regulation we have used a method of cultur-
ing murine SDCs using GM–CSF and TGF-b [27]. This
system has several key features for our purpose. First,
populations of immature dendritic cells are obtained, of
which ~90% show very active macropinocytosis. Second,
using LPS, we can simulate physiological maturation and
effectively downregulate macropinocytosis in virtually all
cells. Third, the use of ex vivo murine cells allows the use
of gene-targeted mice to probe dendritic cell function. For
844 Current Biology Vol 10 No 14
Figure 4
Levels of active Rac and Cdc42 are
maintained on LPS-driven maturation of SDC.
(a) To determine Rac, iSDCs (– LPS) or
mSDCs (+ LPS) were lysed (107
cells/sample) and affinity precipitated with
GST–PAK (PAK) or control GST (upper blot).
Bound proteins were probed on western blots
with an anti-Rac antibody. Control lysates
were loaded with GDP or GTPgS before
GST–PAK precipitation. The lower blot shows
the analysis of 3% of a lysate for levels of total
Rac protein. (b) Determination of Cdc42.
Experiments were carried out as for (a),
except that 1.7 ´ 107 cells were lysed for
each sample and western blots were probed
with an anti-Cdc42 antibody. (c) Lysates of
iSDCs (– LPS) or mSDCs (+ LPS) were
incubated with or without GTPgS, and then
fractionated into fractions enriched in
membrane and cytosol, respectively. Levels of
Rac were assessed by western blotting
following electrophoresis of 100% of the
membrane fraction and 30% of the cytosol
fraction. Quantitation by densitometry
indicated that 17% and 20% of total
recovered Rac was associated with
membrane fractions of iSDC and mSDC,
respectively. Parallel analysis of a cytosolic
marker (AMP-activated kinase) indicated 5%
and 9% contamination of the respective
membrane fractions by cytosol (data not
shown). (d) Vav protein in lysates of iSDC
(–LPS) or mSDC (+LPS) was
immunoprecipitated with anti-Vav or control
antibody (iSDC only, rightmost lanes) and the
western blots probed with specific antibodies
for total Vav protein or for tyrosine-
phosphorylated Vav (P-Tyr).
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example, we recently showed that the actin-severing and
capping protein gelsolin is not required for active ruffling
and macropinocytosis in cultured SDCs [27]. 
Membrane ruffling and macropinocytosis are constitutive
in SDCs, continuing for several hours after GM–CSF,
TGF-b and serum have been removed. This raised the
question of whether Rho-family GTPases would regulate
these activities, as they do exogenously stimulated mem-
brane ruffling and macropinocytosis in other cells. System-
atic testing of dominant-negative mutants or inhibitors of
Rac, Cdc42 and Rho established that there is a require-
ment for Rac function in constitutive macropinocytosis in
dendritic cells. Dominant-negative mutants of Rho-family
GTPases are believed to function by sequestering GEFs,
and therefore preventing the activation of endogenous
GTPases [48]. As some GEFs can activate more than one
Rho family member, at least in vitro, the possibility that an
inhibitory GTPase may actually block activation of other
related GTPases should be considered. In our system,
however, we find that inhibitors of Rac, Rho and Cdc42
produce distinct effects on the actin cytoskeleton and
macropinocytosis in dendritic cells, suggesting that
N17Rac1 does not inhibit macropinocytosis by inhibiting
activation of Rho or Cdc42. N17Cdc42 was a much less
effective inhibitor of macropinosome formation than
N17Rac1, in spite of being able to substantially reduce
actin plaques; similarly, C3 transferase, an independent
inhibitor of Rho, only slightly reduced macropinocytosis
while specifically and completely abolishing actin cables. 
Because membrane ruffling is clearly a prerequisite for
macropinocytosis, and Rac is strongly implicated in regu-
lating ruffling, an unexpected finding was that although
N17Rac1 abolished macropinocytosis in SDCs it did not
eliminate membrane ruffles. Indeed, ruffles also persisted
on iSDCs treated with toxin B and wortmannin and on
LPS-matured mSDCs, all of which had downregulated
macropinocytotic activity (Figure 3). There are various
possible explanations. First, there might be different
types of ruffles that are differentially dependent on Rac
function and differ in their ability to contribute to
macropinosome formation. Membrane ruffles and lamel-
lipodia, generally defined as cell-surface protrusions con-
taining a meshwork of newly polymerised actin filaments,
can take on a variety of appearances depending on cell
type and conditions [49], and there is evidence that not all
ruffles are structurally identical; for example, some ruffles
on chick embryo fibroblasts are distinguishable from
others by their dependence on microtubules [50]. An
alternative possibility might be that in SDCs, Rac is
required for the conversion or closure of membrane ruffles
to form macropinosomes, rather than being required for
ruffling per se. In fact, the idea of regulation of
macropinocytosis at a point downstream of ruffling has
already been proposed for macrophages, where, as we also
find for SDCs, the PI3-K inhibitor wortmannin appeared
to block a late step in macropinosome formation, and not
ruffling as such [51]. Finally, our data do not exclude the
possibility that downstream targets of Rac involved in con-
stitutive ruffling in other cell types are constitutively acti-
vated in SDCs, or could be activated by alternative
mechanisms, perhaps involving members of the Rho
family other than Rac, Cdc42 and Rho.
Although ruffling appeared to be independent of Rac in
SDCs, our data nonetheless indicate that Rac is a key reg-
ulator of macropinocytosis in immature SDCs, leading us
to speculate that macropinosome formation might be
downregulated in mature cells through a reduction in Rac
levels or activity. We found, however, that Rac–GTP
levels were unchanged, or actually increased, in mature
dendritic cells compared to immature cells. Furthermore,
the introduction of constitutively active Rac could not
restore macropinocytosis in mature SDCs. These data
suggest that macropinocytosis is downregulated, at least in
cultured SDCs, by some other mechanism. One possibil-
ity is that one or more effectors of Rac, or elements of the
actin cytoskeleton required for pinosome formation, are
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Figure 5
The constitutively active Rac mutant V12Rac1 does not rescue
macropinocytosis in LPS-matured dendritic cells. iSDCs (– LPS) or
mSDCs (+ LPS) were microinjected with APC–NLS with or without
V12Rac1 protein. The cells were exposed to FITC–dextran for 10 min
and viable injected cells and neighbouring non-injected cells were
scored for the presence of any labelled macropinosomes (77
V12Rac1-injected cells were scored). Note the failure of V12Rac1 to
induce macropinocytosis in LPS-treated cells over the background
levels seen in surrounding non-injected cells. 
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differentially expressed in immature versus mature den-
dritic cells. Alternatively, the signalling pathway may be
modified in mature cells at the level of upstream regula-
tors of Rac, for example by expression of different GEFs,
which could affect the specificity of downstream events
without greatly changing net levels of active Rac [52].
Garrett and colleagues have recently completed a similar
analysis of developmental regulation of endocytosis in
murine dendritic cells derived from bone marrow rather
than spleen (I. Mellman, personal communication). In this
system, regulation of endocytosis appears to be controlled
by the levels of active Cdc42. Indeed, macropinocytosis in
mature cells could be rescued by microinjection of active
Cdc42. The reasons for the differences in these two
studies are not yet clear;  it is, however,  important to note
that both the source of dendritic cell precursors and the
culture conditions were different. Our spleen cultures
were usually 14–28-day cells cultured with GM–CSF and
TGF-b whereas the bone-marrow cultures were shorter
term and did not include TGF-b. TGF-b is known to be
required for outgrowth of Langerhans-type dendritic cells,
for example, from CD34+ precursors [29,30,53], although
we do not know how closely our cells resemble Langer-
hans cells. Conceivably, the spleen and bone-marrow den-
dritic cell populations may differentially express Rho
GTPases and/or effectors, which could account for the dif-
ferences in regulation. Taken together, these data indicate
that dendritic cells might use different strategies to regu-
late endocytosis in response to environmental stimuli. As
Rho-family GTPases are, however, likely to be required
for events such as dendritic cell migration and interaction
with T cells, which take place downstream of the early
phase of constitutive endocytosis, it may be advantageous
to maintain active GTPases and instead modulate down-
stream effector systems. Analysis of the changes in gene
expression that take place on dendritic cell maturation
may provide further information. 
Materials and methods
Cell culture
Dendritic cell populations from the spleens of 8–16-week-old female
C57BL/6 mice were expanded in low-attachment six-well plates
(Corning-Costar) in the presence of 20 ng/ml GM–CSF and 1 ng/ml
TGF-b as described previously [27]. Cells were generally used after
14–28 days of culture. Where indicated, the cultures were treated with
LPS (Escherichia coli 026:B6; Sigma) at 1 mg/ml for 40 h to induce
maturation. A representative FACS analysis of day 0 spleen and the
day 14 immature DC population can be seen in Supplementary mater-
ial. The mouse B-lymphoma line A20 and thymoma line EL4 were main-
tained in RPMI medium supplemented with 10% FCS, 1 mM pyruvate,
1´ non-essential amino acids, 2 mM glutamine, 100 mg/ml kanamycin
and 50 mM b-mercaptoethanol (complete RPMI). 
Fusion proteins and probes
Recombinant GST fusion proteins with V12Rac1, V12A35Rac1,
V12N17Rac1, N17Cdc42, C. botulinum C3 transferase (a gift from L.
Feig) and the PAK CRIB domain (human PAK1B amino acids
59–272, kindly provided by A. Hall) were expressed and purified
essentially as described in [13], with the following exceptions. For
GST–PAK purification, the bacterial lysates additionally contained
0.5% Triton X-100 and 10% glycerol, and GST–PAK was eluted from
the glutathione–sepharose beads with 15 mM glutathione, before dial-
ysis against 100 mM NaCl, 50 mM Tris-HCl pH 7.5, 5 mM MgCl2,
1 mM DTT and 10% glycerol. The GST moiety of the other fusion pro-
teins was removed by digestion while still bound to the
glutathione–agarose beads, in 100 mM NaCl, 50 mM Tris-HCl pH 7.5,
2.5 mM CaCl2, 5 mM MgCl2, 1 mM DTT, with bovine thrombin (Sigma)
at 5 U per ml of beads for 1 h at room temperature. The supernatants
that contained the GST-free proteins were treated with p-aminobenza-
midine–agarose (Sigma) to remove thrombin, before dialysis against
100 mM KCl, 20 mM Hepes pH 7.3, 2.5 mM MgCl2, 1 mM DTT
(microinjection buffer) and concentration. All fusion proteins were
snap-frozen in small aliquots and stored at –80°C.
Allophycocyanin (Calbiochem) was chemically coupled to a synthetic
peptide containing the SV40 large T antigen nuclear localisation signal
(CGGGPKKKRKVED) as described [54], dialysed into microinjection
buffer and stored as small aliquots at –80°C.
Microinjection 
SDCs (2.5 ´ 105) were plated on 13 mm glass coverslips in complete
RPMI medium for 2–3 h before microinjection. The cells were co-injected
in the cytoplasm with APC–NLS at 2 mg/ml and recombinant proteins,
as indicated, at the following total protein concentrations: V12Rac1
(1.3 mg/ml), V12A35Rac1 (0.4 mg/ml), V12N17Rac (0.4 mg/ml),
N17Cdc42 (0.7 mg/ml), C3 transferase (2 mg/ml). Approximately
150 cells per coverslip were injected in 10 min using an Eppendorf Tran-
sjector 5246 and a Zeiss Axiovert 100 microscope fitted with a 37°C
heated chamber. The cells were further incubated for 20 min at 37°C
before FITC–dextran internalisation or fixation and staining for actin.
FITC–dextran uptake and fluorescence microscopy
Macropinocytosis was assessed by FITC–dextran uptake as described
previously [27]. For the non-adherant A20 and EL4 cell lines, 2 ´ 105
cells were centrifuged onto slides at 200 rpm for 2 min (Shandon
Cytospin 3) before fixation. Where indicated, cells were treated for
30 min with 100 ng/ml toxin B before uptake, or were pretreated for
15 min with 100 nM wortmannin (Alexis Biochemicals), then wortman-
nin was included in the FITC–dextran incubation. Actin structures were
visualised after fixation and staining with TRITC–phalloidin as described
previously [27]. Images were collected on a Zeiss LSM 410 laser scan-
ning microscope using a ´63, NA1.4 Planapochromatic objective. 
Affinity precipitation, immunoprecipitation and cell
fractionation
For affinity precipitation of active Rac and Cdc42, SDCs were resus-
pended at 107cells/ml in 100 mM NaCl, 25 mM Tris-HCl pH 7.5, 1% NP-
40, 5% glycerol, 5 mM MgCl2 containing leupeptin (50 mM), pepstatin A
(10 mM), chymostatin (10 mg/ml) and AEBSF (100 mg/ml; ICN). GST or
GST–PAK (25 mg) was added immediately to each sample. After lysis for
15 min at 4°C and centrifugation at 2500 g for 5 min to remove debris,
25 ml of glutathione–sepharose suspension was added, and the samples
incubated for 30 min at 4°C with mixing. Control lysates were treated
with 10 mM EDTA for 20 min at 30°C in the presence of 1 mM GDP or
0.5 mM GTPgS, then MgCl2 was added to 30 mM before precipitation
with GST–PAK and glutathione–sepharose. Precipitated complexes
were washed four times with lysis buffer, then analysed by western blot-
ting. Rac and Cdc42 were detected using monoclonal antibody 23A8
and polyclonal anti-Cdc42 (Santa Cruz), respectively. For immunoprecipi-
tation of Vav, SDCs (8 ´ 106) were lysed in 40 mM NaCl, 20 mM Tris-
HCl pH 7.4, 5 mM EDTA, 1% Triton X-100, containing phosphatase
inhibitors NaF (50 mM), Na4P2O7 (30 mM), Na3VO4 (1 mM) and pro-
tease inhibitors as above. Lysates were immunoprecipitated with 5 mg
anti-Vav polyclonal antibody (UBI) and protein A–sepharose and total Vav
or tyrosine-phosphorylated Vav was detected by western blotting using
the same anti-Vav antibody or monoclonal PY-20 (Transduction Labs).
Detection with PY-20 could be completely competed by the inclusion of
2.5 mM o-phosphotyrosine (data not shown).
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For membrane fractionation, SDCs (5 ´ 106/sample) were resuspended
in lysis/breakage buffer [55], broken by 10 passages through a ball-
bearing homogeniser, and post-nuclear supernatants (PNS) prepared
by centrifugation at 1000 ´ g for 10 min. In control samples, PNS were
incubated with 1 mM GTPgS for 10 min at 37°C. Membrane and cytosol
fractions were separated at 100,000 ´ g for 20 min at 4°C, and the
membranes washed once in lysis/breakage buffer to remove contami-
nating cytosolic proteins. Rac levels in each fraction were measured by
western blotting.
Supplementary material
Supplementary material including a FACS analysis of a representative
SDC population is available at http://current-biology.com/supmat/sup-
matin.htm.
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